Q2 2025 Bionano Genomics Inc Earnings Call Transcript
Key Points
- Bionano Genomics Inc (BNGO) reported a significant increase in non-GAAP gross margin to 52% from 35% a year ago, indicating improved profitability.
- The company achieved a 17% year-over-year increase in flow cell sales, reflecting strong demand and utilization among existing customers.
- Bionano Genomics Inc (BNGO) successfully reduced non-GAAP operating expenses by 53% year-over-year, showcasing effective cost management.
- The company has made substantial progress in AI-driven software development, with VIA software being widely accepted as a gold standard for CNV analysis.
- Bionano Genomics Inc (BNGO) has seen a significant increase in publications supporting optical genome mapping, with the highest number of publications in any quarter in its history.
- Total revenue for the second quarter was $6.7 million, a decrease of 13% compared to the same period in 2024, indicating a decline in overall sales.
- The company experienced a net decrease of one in the installed base of optical genome mapping systems, reflecting challenges in expanding its customer base.
- Bionano Genomics Inc (BNGO) brought back eight systems during the quarter, suggesting some customers are not continuing with their initial contracts.
- The adoption rate of VIA software among the entire installed base of OGM systems is relatively low, with only about a third of systems having it installed.
- The company faces challenges in achieving routine use of its systems, with a significant portion of new systems potentially subject to return after evaluation periods.
Good day. Welcome to the Bionano second-quarter 2025 earnings conference call.
Today's conference is being recorded.
At this time, I would like to turn the conference over to Kelly Gura from Investor Relations.
Thank you. Good afternoon, everyone. Welcome to the Bionano second-quarter 2025 financial results conference call.
Leading the call today is Dr. Erik Holmlin, CEO and Principal Financial Officer of Bionano. He is joined by Mark Adamchak, Bionano's Vice President of Accounting and Principal Accounting Officer.
After market closed today, Bionano issued a press release announcing its financial results for the second quarter of 2025. A copy of the release can be found on the Investor Relations page of the company's website.
Certain statements made during this conference call may be forward-looking statements. Actual results may differ materially from such statements due to several factors and risks, some of which are identified in Bionano's press release and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
